CYPH CYPHERPUNK TECHNOLOGIES INC.

NEUTRAL Impact: 3/10 8-K
Horizon days Filed May 26, 2026 Processed 18d 1h ago SEC 0001104659-26-066019
8-K context-dependent: Items 8.01
Latest settled — T+5d
CYPH ▼ -9.48% at T+5d
NEUTRAL call ✗ call lost -9.48% · α vs SPY -10.57% · entry $1.16 → $1.05
Next anchor: T+20d in 11d
Currently $0.6500 · -43.97% from $1.16 entry
Entry anchored
May 22, 03:59 PM ET
via Databento tick
T+1d
-7.76%
call -7.76% · α -7.77%
$1.07
settled 17d ago
T+5d
-9.48%
call -9.48% · α -10.57%
$1.05
settled 11d ago
T+20d
call — · α —
in 11d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Cypherpunk Technologies received a Nasdaq notice on May 21, 2026, confirming it has regained compliance with the minimum $1.00 bid price requirement, closing a previously disclosed deficiency matter from March 4, 2026. This removes the near-term delisting risk from Nasdaq, but the filing contains no financial data, guidance, or operational updates.

Actionable Insight

The delisting risk is removed, which may provide a small near-term sentiment boost. However, with 0% analyst bullishness and no fundamental catalyst, this is a routine compliance update. Monitor for upcoming quarterly results to assess the business trajectory.

Key Facts

  • Nasdaq notified CYPH on May 21, 2026 that it regained compliance with Listing Rule 5550(a)(2) (minimum bid price).
  • The deficiency period began March 4, 2026 when the stock closed below $1.00 for 30 consecutive business days.
  • No financial results, guidance, or other material operational information was disclosed.
  • The compliance matter is now closed with no further action required.

Financial Impact

No financial data disclosed. Removal of delisting risk is a modest procedural positive but has no quantifiable dollar impact.

Risk Factors

  • Stock price could again fall below $1.00, triggering another deficiency period.
  • No operational or financial improvement was announced—fundamental risks remain unchanged.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-066019
Document: 0001104659-26-066019-index-headers.html0001104659-26-066019
Document: 0001104659-26-066019-index.html0001104659-26-066019
Document: 0001104659-26-066019.txt0001104659-26-066019
4 reports for CYPH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYPH — sortable, filterable
Type Now
May 26, 2026
18d ago
8-K
NEUTRAL ★ 3/10
$1.16 $1.05▼ −9.48%▼ −10.57%$0.6500 (−43.97%)
May 14, 2026
4w ago
8-K
BEARISH ★ 6/10
$1.20 $1.31▼ −9.17%▼ −9.88%$0.6500 (+45.83%)
Apr 10, 2026
9w ago
8-K
NEUTRAL ★ 3/10
$0.9900 $0.8690▼ −12.22%▼ −15.52%$0.6500 (−34.34%)
Mar 27, 2026
11w ago
144
NEUTRAL ★ 3/10
$0.6570 $0.7700▲ +17.20%▲ +13.34%$0.6500 (−1.07%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (48h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access